1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Immunosuppressive activities of GutMagnificTM –a probiotic product designed to rebalance the gut flora and modulate the immune system – in a model for multiple sclerosis
- Master (Two yrs)
- 2019
-
Mark
Therapeutic efficacy of GutMagnific™ – a scientifically designed consortium of probiotic bacteria against IBS – in an animal model for multiple sclerosis
- Bach. Degree
- 2015
-
Mark
Predicting in vivo therapeutic efficacy of probiotics in a mouse model of Multiple Sclerosis, based on a novel in vitro Peyer’s Patch cell culture system
- Master (Two yrs)
-
Mark
Comparison of serum levels of inflammatory marker Calprotectin, indicating intestinal inflammation, in patients with Sjögren´s syndrome versus patients with IBD, and detection of autoreactive T cells
- Master (Two yrs)